Mortality reduction by post-dilution online-haemodiafiltration: A cause-specific analysis
Files
Publication date
2017-03
Authors
Nubé, Menso J.
Peters, S. A E
Blankestijn, Peter J.
Canaud, Bernard
Davenport, Andrew
Grooteman, Muriel P C
Asci, Gulay
Locatelli, Francesco
Maduell, Francisco
Morena, Marion
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Background. From an individual participant data (IPD) meta-analysis from four randomized controlled trials comparing haemodialysis (HD) with post-dilution online-haemodiafiltration (ol-HDF), previously it appeared that HDF decreases all-cause mortality by 14% (95% confidence interval 25; 1) and fatal cardiovascular disease (CVD) by 23% (39; 3). Significant differences were not found for fatal infections and sudden death. So far, it is unclear, however, whether the reduced mortality risk of HDF is only due to a decrease in CVD events and if so, which CVD in particular is prevented, if compared with HD. Methods. The IPD base was used for the present study. Hazard ratios and 95% confidence intervals for cause-specific mortality overall and in thirds of the convection volume were calculated using the Cox proportional hazard regression models. Annualized mortality and numbers needed to treat (NNT) were calculated as well. Results. Besides 554 patients dying from CVD, fatal infections and sudden death, 215 participants died from 'other causes', such as withdrawal from treatment and malignancies. In this group, the mortality risk was comparable between HD and ol-HDF patients, both overall and in thirds of the convection volume. Subdivision of CVD mortality in fatal cardiac, non-cardiac and unclassified CVD showed that ol-HDF was only associated with a lower risk of cardiac casualties [0.64 (0.61; 0.90)]. Annual mortality rates also suggest that the reduction in CVD death is mainly due to a decrease in cardiac fatalities, including both ischaemic heart disease and congestion. Overall, 32 and 75 patients, respectively, need to be treated by high-volume HDF (HV-HDF) to prevent one all-cause and one CVD death, respectively, per year. Conclusion. The beneficial effect of ol-HDF on all-cause and CVD mortality appears to be mainly due to a reduction in fatal cardiac events, including ischaemic heart disease as well as congestion. In HV-HDF, the NNT to prevent one CVD death is 75 per year.
Keywords
cardiovascular disease, convection volume, haemodiafiltration, meta-analysis, mortality, Taverne, Nephrology, Transplantation, Journal Article
Citation
Nubé, M J, Peters, S A E, Blankestijn, P J, Canaud, B, Davenport, A, Grooteman, M P C, Asci, G, Locatelli, F, Maduell, F, Morena, M, Ok, E, Torres, F, Bots, M L, Moreso, F, Pons, M, Ramos, R, Mora-Macià, J, Carreras, J, Soler, J, Campistol, J M, Martinez-Castelao, A, Insensé, B, Perez, C, Feliz, T, Barbetta, M, Soto, C, Mora, J, Juan, A, Ibrik, O, Foraster, A, Nin, J, Fernández, A, Arruche, M, Sánchez, C, Vidiella, J, Barbosa, F, Chiné, M, Hurtado, S, Llibre, J, Ruiz, A, Serra, M, Salvó, M, Poyuelo, T, Maduell, F, Carrera, M, Fontseré, N, Arias, M, Merín, A, Ribera, L, Galceran, J M, Mòdol, J, Moliner, E, Ramirez, A, Aguilera, J, Alvarez, M, De La Torre, B, Molera, M, Casellas, J, Martín, G, Andres, E, Coll, E, Valles, M, Martínez, C, Castellote, E, Casals, J M, Gabàs, J, Romero, M, Martinez-Castelao, A, Fulladosa, X, Ramirez-Arellano, M, Fulquet, M, Pelegrí, A, El Manouari, M, Ramos, N, Bartolomé, J, Sans, R, Fernández, E, Sarró, F, Compte, T, Marco, F, Mauri, R, Bronsoms, J, Arnaiz, J A, Beleta, H, Pejenaute, A, Ríos, J, Lara, J, Ter Wee, P M, Van Den Dorpel, M A, Dorval, M, Lévesque, R, Koopman, M G, Konings, C J A M, Haanstra, W P, Kooistra, M, Van Jaarsveld, B, Noordzij, T, Feith, G W, Peltenburg, H G, Van Buren, M, Offerman, J J G, Hoogeveen, E K, De Heer, F, Van De Ven, P J, Kremer Hovinga, T K, Bax, W A, Groeneveld, J O, Lavrijssen, A T J, Schrander-Van Der Meer, A M, Reichert, L J M, Huussen, J, Rensma, P L, Schrama, Y, Van Hamersvelt, H W, Boer, W H, Van Kuijk, W H, Vervloet, M G, Wauters, I M P M J, Sekse, I, Toz, H, Ok, E S, Kircelli, F, Yilmaz, M, Hur, E, Demirci, M S, Demirci, C, Duman, S, Basci, A, Adam, S M, Isik, I O, Zengin, M, Suleymanlar, G, Yilmaz, M E, Ergin, M O P, Sagdic, A, Kayali, E, Boydak, C, Colak, T, Caliskan, S, Kaplan, H, Ulas, H, Kirbiyik, S, Berktas, H, Dilbaz, N, Cristol, J P, Leray-Moragues, H, Chenine, L, Picot, M C, Jaussent, A, Belloc, C, Lagarrigue, M, Chalabi, L, Debure, A, Ouziala, M, Lefevre, J J, Thibaudin, D, Mohey, H, Broyet, C, Afiani, A, Serveaux, M O, Patrier, L, Maurice, F, Rivory, J P, Nicoud, P, Durand, C, Normand, M, Seigneuric, B, Magnant, E, Azzouz, L, Islam, M S, Vido, S, Nzeyimana, H, Simonin, D, Azymah, Y, Farah, I, Coindre, J P, Puyoo, O, Chabannier, M H, Ibos, R, Rouleau, F, Vela, C, Joule, J, Combarnous, F, Turc-Baron, C, Ducret, F, Pointet, P, Rey, I, Potier, J, Bendini, J C, Perrin, F, Kunz, K, Lefrancois, G, Colin, A, Parahy, S, Dancea, I, Coupel, S, Testa, A, Brunet, P, Lebrun, G, Jaubert, D, Delcroix, C, Lavainne, F, Lefebvre, A, Guillodo, M P, Le Grignou, D, Djema, A, Maaz, M, Chiron, S, Hoffmann, M, Depraetre, P, Haddj-Elmrabet, A, Joyeux, V, Fleury, D, Vrigneaud, L, Lemaitre, V, Aguilera, D, Guerraoui, A, Cremault, A, Laradi, A & Babinet, F 2017, 'Mortality reduction by post-dilution online-haemodiafiltration : A cause-specific analysis', Nephrology Dialysis Transplantation, vol. 32, no. 3, pp. 548-555. https://doi.org/10.1093/ndt/gfw381